Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.

The results open the possibility of using cellular virotherapy for the treatment of bone cancers. Indeed, its combination with G-CSF may be considered for the improvement of the therapy.